Emanuelle Wakselman - Galapagos SASU, R&D

基本信息

Career Trajectory

Bio

No content for now

Research Interests

Papers共 8 篇Author StatisticsCo-AuthorSimilar Experts

By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选

Discovery of Clinical Candidate GLPG3970: A Potent and Selective Dual SIK2/SIK3 Inhibitor for the Treatment of Autoimmune and Inflammatory Diseases

Journal of Medicinal Chemistryno. 7 (2024): 5233-5258

Cited3Views0WOSBibtex

Discovery of 2-[[2-Ethyl-6-[4-[2-(3-hydroxyazetidin-1-yl)-2-oxoethyl]piperazin-1-yl]-8-methylimidazo[1,2-a]pyridin-3-yl]methylamino]-4-(4-fluorophenyl)thiazole-5-carbonitrile (GLPG1690), a First-in-Class Autotaxin Inhibitor Undergoing Clinical Evaluation for the Treatment of Idiopathic Pulmonary Fibrosis

JOURNAL OF MEDICINAL CHEMISTRY（2017）

Cited120Views0WOSBibtex

120

Pharmacological Profile and Efficacy of Glpg1690, A Novel Atx Inhibitor for Copd Treatment

Roland Blanque,Nicolas Desroy,Sonia Dupont,Celine Cottereaux,Alain Monjardet,Emanuelle Wakselman,Wendy Laenen,Vince Russell,Ellen Van der Aar,Reginald Brys,Bertrand Heckmann

51 Airway Pharmacology and Treatment（2015）

Cited6Views0Bibtex

Author Statistics

Co-Author

Co-Institution

D-Core

合作者
学生
导师

No result temporarily, you can search similar Scholar with the same research interest

Data Disclaimer

The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn